-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on ESAB, Lowers Price Target to $110

Benzinga·10/21/2026 17:03:33
Listen to the news
Oppenheimer analyst Bryan Blair maintains ESAB (NYSE:ESAB) with a Outperform and lowers the price target from $135 to $110.